These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7141706)

  • 1. Increased severity of urinary tract infection and bacteremia in mice with urinary bladder injury induced by cyclophosphamide.
    Lyon D; Howard EB; Montgomerie JZ
    Infect Immun; 1982 Nov; 38(2):558-62. PubMed ID: 7141706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary tract infection after injection of pseudomonas into bladder.
    Montgomerie JZ; Morrow JW; Howard EB
    Urology; 1981 May; 17(5):454-6. PubMed ID: 6785919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide and the urinary bladder.
    Hansen HH; Muggia FM; Saini N
    N Engl J Med; 1971 May; 284(18):1043-4. PubMed ID: 5553480
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental urinary tract infection with Pseudomonas aeruginosa in mice.
    Nishi T; Tsuchiya K
    Infect Immun; 1978 Nov; 22(2):508-15. PubMed ID: 103833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine uromodulin estimation in partial bladder outlet obstruction and cyclophosphamide-induced haemorrhagic cystitis models in rats.
    Dobrek Ł; Kaszuba-Zwoińska J; Skowron B; Baranowska A; Thor PJ
    Postepy Hig Med Dosw (Online); 2014 Sep; 68():1184-92. PubMed ID: 25228527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder toxicity with chronic oral cyclophosphamide therapy in nonmalignant disease.
    Aptekar RG; Atkinson JP; Decker JL; Wolff SM; Chu EW
    Arthritis Rheum; 1973; 16(4):461-7. PubMed ID: 4722431
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction.
    Vizzard MA
    Exp Neurol; 2000 Jan; 161(1):273-84. PubMed ID: 10683293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of murine bladder permeability with fluorescein: validation with cyclophosphamide and protamine.
    Eichel L; Scheidweiler K; Kost J; Shojaie J; Schwarz E; Messing E; Wood R
    Urology; 2001 Jul; 58(1):113-8. PubMed ID: 11445501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of taurine against cyclophosphamide-induced urinary bladder toxicity in rats.
    Abd-Allah AR; Gado AM; Al-Majed AA; Al-Yahya AA; Al-Shabanah OA
    Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):167-72. PubMed ID: 15743398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effects of spirulina in cyclophosphamide induced nephrotoxicity and urotoxicity in rats.
    Sinanoglu O; Yener AN; Ekici S; Midi A; Aksungar FB
    Urology; 2012 Dec; 80(6):1392.e1-6. PubMed ID: 22951000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic-microbiologic correlates of invasiveness in a mouse model of ascending unobstructed urinary tract infection.
    Johnson JR; Berggren T; Manivel JC
    J Infect Dis; 1992 Feb; 165(2):299-305. PubMed ID: 1730896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin-Ciprofloxacin-Impregnated Urinary Catheters Avert Bacterial Colonization, Biofilm Formation, and Inflammation in a Murine Model of Foreign-Body-Associated Urinary Tract Infections Caused by Pseudomonas aeruginosa.
    Saini H; Vadekeetil A; Chhibber S; Harjai K
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031194
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study.
    Freedman A; Ehrlich RM; Ljung BM
    J Urol; 1984 Sep; 132(3):580-2. PubMed ID: 6433044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional, histological structure and mastocytes alterations in rat urinary bladders following acute and [corrected] chronic cyclophosphamide treatment.
    Juszczak K; Gil K; Wyczolkowski M; Thor PJ
    J Physiol Pharmacol; 2010 Aug; 61(4):477-82. PubMed ID: 20814076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Errors and pitfalls in cytology of the lower urinary tract.
    Koss LG
    Monogr Pathol; 1997; (39):60-74. PubMed ID: 9249820
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclophosphamide necrosis of bladder causing calcification, contracture and reflux; treated by colocystoplasty.
    Marsh FP; Vince FP; Pollock DJ; Blandy JP
    Br J Urol; 1971 Jun; 43(3):324-32. PubMed ID: 4933887
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclophosphamide cystitis with bladder wall calcification.
    Francis RS; Shackelford GD
    J Can Assoc Radiol; 1974 Dec; 25(4):324-6. PubMed ID: 4531432
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective study of urinary tract infections and urinary antibodies after radical prostatectomy and cystoprostatectomy.
    Iwakiri J; Freiha FS; Shortliffe LM
    Urol Clin North Am; 2002 Feb; 29(1):251-8, xii. PubMed ID: 12109353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary bladder complications with cyclophosphamide therapy.
    Foad BS; Hess EV
    Arch Intern Med; 1976 May; 136(5):616-9. PubMed ID: 1267567
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation.
    Turkeri LN; Lum LG; Uberti JP; Abella E; Momin F; Karanes C; Sensenbrenner LL; Haas GP
    J Urol; 1995 Mar; 153(3 Pt 1):637-40. PubMed ID: 7861502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.